Differential inhibition of morphine glucuronidation in the 3- and 6-position by ranitidine in isolated hepatocytes from guinea pig

被引:7
作者
Aasmundstad, TA [1 ]
Morland, J [1 ]
机构
[1] Natl Inst Forens Toxicol, N-0105 Oslo, Norway
来源
PHARMACOLOGY & TOXICOLOGY | 1998年 / 82卷 / 06期
关键词
D O I
10.1111/j.1600-0773.1998.tb01573.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of ranitidine on morphine metabolism, with special emphasise on the ratio between morphine-3-glucuronide and morphine-6-glucuronide was studied in isolated guinea pig hepatocytes. Ranitidine reduced the K-el of morphine dose-dependently with a maximum effect of 50%, and increased the relative concentration of morphine-6-glucuronide to morphine-3-glucuronide. These effects could be due to a direct or indirect effect on the conjugation enzymes involved, or an effect on the transport of morphine or glucuronides across cell membranes. The latter explanation was rejected on the basis of the observation that the ratios between intra-and extracellular concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide were not influenced by ranitidine. Increasing concentrations of ranitidine gradually decreased the morphine-3-glucuronide/morphine-6-glucuronide ratio by up to 21%. This could stem from interference of energy or co-substrate supply, or through direct effects on the different UDPGTases involved. The observation that the present effect on morphine glucuronidation was the opposite of that observed when administering a known co-substrate (UDPGA) depletor, indicated that in all probability the effect of ranitidine was a direct inhibition on the uridine 5'-diphosphate glucuronyltransferases involved, with a more pronounced effect for the isoenzymes responsible for the 3'-glucuronidation.
引用
收藏
页码:272 / 279
页数:8
相关论文
共 46 条
  • [21] LACK OF EFFECT OF CERTAIN HISTAMINE-H2-RECEPTOR BLOCKERS ON THE GLUCURONIDATION OF 7-HYDROXY-4-METHYLCOUMARIN BY HUMAN LIVER-MICROSOMES
    IRSHAID, Y
    ABUKHALAF, M
    [J]. PHARMACOLOGY & TOXICOLOGY, 1992, 71 (04): : 294 - 296
  • [22] IWAMOTO K, 1978, J PHARMACOL EXP THER, V206, P181
  • [23] JELLEMA JG, 1987, LANCET, V2, P392
  • [24] KNODELL RG, 1982, GASTROENTEROLOGY, V82, P84
  • [25] DIFFERENTIAL INHIBITION OF HEPATIC MORPHINE UDP-GLUCURONOSYLTRANSFERASES BY METAL-IONS
    LAWRENCE, AJ
    MICHALKIEWICZ, A
    MORLEY, JS
    MACKINNON, K
    BILLINGTON, D
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 43 (11) : 2335 - 2340
  • [26] MORPHINE-3-GLUCURONIDE - SILENT REGULATOR OF MORPHINE ACTIONS
    LIPKOWSKI, AW
    CARR, DB
    LANGLADE, A
    OSGOOD, PF
    SZYFELBEIN, SK
    [J]. LIFE SCIENCES, 1994, 55 (02) : 149 - 154
  • [27] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [28] RANITIDINE-INDUCED CONFUSION WITH CONCOMITANT MORPHINE
    MARTINEZABAD, M
    GOMIS, FD
    FERRER, JM
    MORALESOLIVAS, FJ
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (11): : 914 - 915
  • [29] ORAL MORPHINE IN CANCER PAIN - INFLUENCES ON MORPHINE AND METABOLITE CONCENTRATION
    MCQUAY, HJ
    CARROLL, D
    FAURA, CC
    GAVAGHAN, DJ
    HAND, CW
    MOORE, RA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) : 236 - 244
  • [30] CARRIER-MEDIATED TRANSPORT IN THE HEPATIC DISTRIBUTION AND ELIMINATION OF DRUGS, WITH SPECIAL REFERENCE TO THE CATEGORY OF ORGANIC CATIONS
    MEIJER, DKF
    MOL, WEM
    MULLER, M
    KURZ, G
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1990, 18 (01): : 35 - 70